| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |